KAKatia Andrade

Katia Andrade

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Katia Andrade has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • Thomas Guieysse

    Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, AP-HP, Pitié-Salpêtrière Hospital, 75013 Paris, France

    8 shared publications
  • Dimitrios Pantazis

    Massachusetts Institute of Technology, Cambridge, MA, USA

    7 shared publications
  • Takfarinas Medani

    University of Southern California, Los Angeles, CA, USA

    7 shared publications
  • Solofo Razafimahatratra

    Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, AP-HP, Pitié-Salpêtrière Hospital, 75013 Paris, France

    6 shared publications
  • André Klarsfeld

    Laboratory of Brain Plasticity, CNRS UMR 8249, ESPCI Paris - PSL, Paris, France

    5 shared publications
  • Bruno Dubois

    Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, AP-HP, Pitié-Salpêtrière Hospital, 75013 Paris, France

    5 shared publications

Latest Publications

  • Open Access

    Error unawareness as a driver of cognitive decline in individuals at risk for Alzheimer’s disease

    by Katia Andrade, François-Xavier Lejeune, Nesma Houmani, Rita Yabouri, Michel Thiebaut de Schotten, Valentina Pacella

    Anosognosia, or unawareness of one’s deficits, predicts faster clinical progression in Alzheimer’s disease (AD), though its mechanisms remain unclear. We investigated five-year trajectories of response awareness and error-monitoring efficiency using second-order judgments from an annual word recognition memory task in cognitively unimpaired individuals at risk for AD from the INSIGHT-preAD cohort. Participants were divided into three groups according to amyloid status at baseline (positive, A + ; negative, A–) and clinical progression (controls, CTRL A+ or A–; and progressors, PROG). Task accuracy declined in PROG, while CTRL A+ showed continued learning, and CTRL A– remained accurate. Inefficient error-monitoring predicted subsequent performance decline in the PROG, with a strong interaction between accuracy and error-monitoring already at baseline. This effect was primarily driven by error unawareness. These findings provide first evidence that error unawareness — a core feature of anosognosia — may foster cognitive decline through the disruption of error-feedback learning mechanisms, potentially accelerating AD progression.

  • Open Access

    The Interplay between Emotional processing and Error‐monitoring as a relevant mechanism in the Self‐awareness loop ‐ Evidence from the ADNI cohort

    by Katia Andrade, Patrick Maloyan, Dimitrios Pantazis, Swapna Mahurkar‐Joshi, Takfarinas Medani, Anand A Joshi, Richard Leahy

    Background: Lack of awareness of deficits, known as anosognosia, is a very impressive neuropsychiatric symptom of Alzheimer's disease (AD). It often appears in the early stages of the disease and worsens over time. Method: According to our dual‐path hypothesis, the occurrence of anosognosia in AD would depend on a critical failure of the error‐monitoring system, reflecting either (i) local alterations in the cingulate cortex (direct pathway), with particular emphasis on its anterior and posterior parts (ACC and PCC, key brain regions at the origin of error‐related potentials, ErrP); and/or (ii) an inability to link error‐monitoring and emotional processing for adaptive behavior due to impairments in the latter system (indirect pathway), mainly affecting the orbitofrontal cortex (OFC) and the amygdala. This study focused on a subgroup of the longitudinal ADNI cohort characterized by 125 subjects who progressed from mild cognitive impairment, MCI, to AD. Our main goal was to investigate which brain structures and specific areas, without any a priori out of a total of 360, contributed the most to unawareness of deficits over time. Result: The results show that self‐awareness deterioration correlated with cortical thickness changes in specific areas of two brain structures: the OFC (area p32, right hemisphere, p  p  = 0.051, corrected) and the ACC (area a24, left hemisphere, p  = 0.051, corrected) . Conclusion: These findings strongly support our dual‐path model for the emergence of anosognosia in AD, bringing to the front the relevance of the indirect pathway, linking emotional processing to error‐monitoring, in the self‐awareness loop.

  • Open Access

    The unique role of anosognosia in the clinical progression of Alzheimer’s disease: a disorder-network perspective

    by Katia Andrade, Valentina Pacella

    Alzheimer’s disease (AD) encompasses a long continuum from a preclinical phase, characterized by neuropathological alterations albeit normal cognition, to a symptomatic phase, marked by its clinical manifestations. Yet, the neural mechanisms responsible for cognitive decline in AD patients remain poorly understood. Here, we posit that anosognosia, emerging from an error-monitoring failure due to early amyloid-β deposits in the posterior cingulate cortex, plays a causal role in the clinical progression of AD by preventing patients from being aware of their deficits and implementing strategies to cope with their difficulties, thus fostering a vicious circle of cognitive decline.


  • Open Access

    Self-Modulation of Gamma-Band Synchronization through EEG-Neurofeedback Training in the Elderly

    by Katia Andrade, Nesma Houmani, Thomas Guieysse, Solofo Razafimahatratra, André Klarsfeld, Gérard Dreyfus, Bruno Dubois, François Vialatte, Takfarinas Medani

    Background: Electroencephalography (EEG) stands as a pivotal non-invasive tool, capturing brain signals with millisecond precision and enabling real-time monitoring of individuals’ mental states. Using appropriate biomarkers extracted from these EEG signals and presenting them back in a neurofeedback loop offers a unique avenue for promoting neural compensation mechanisms. This approach empowers individuals to skillfully modulate their brain activity. Recent years have witnessed the identification of neural biomarkers associated with aging, underscoring the potential of neuromodulation to regulate brain activity in the elderly. Methods and Objectives: Within the framework of an EEG-based brain-computer interface, this study focused on three neural biomarkers that may be disturbed in the aging brain: Peak Alpha Frequency, Gamma-band synchronization, and Theta/Beta ratio. The primary objectives were twofold: (1) to investigate whether elderly individuals with subjective memory complaints can learn to modulate their brain activity, through EEG-neurofeedback training, in a rigorously designed double-blind, placebo-controlled study; and (2) to explore potential cognitive enhancements resulting from this neuromodulation. Results: A significant self-modulation of the Gamma-band synchronization biomarker, critical for numerous higher cognitive functions and known to decline with age, and even more in Alzheimer’s disease (AD), was exclusively observed in the group undergoing EEG-neurofeedback training. This effect starkly contrasted with subjects receiving sham feedback. While this neuromodulation did not directly impact cognitive abilities, as assessed by pre- versus post-training neuropsychological tests, the high baseline cognitive performance of all subjects at study entry likely contributed to this result. Conclusion: The findings of this double-blind study align with a key criterion for successful neuromodulation, highlighting the significant potential of Gamma-band synchronization in such a process. This important outcome encourages further exploration of EEG-neurofeedback on this specific neural biomarker as a promising intervention to counter the cognitive decline that often accompanies brain aging and, eventually, to modify the progression of AD.


  • Open Access

    A short‐hybrid scale for detecting anosognosia from the prodromal stage of Alzheimer’s disease

    by Katia Andrade, Thomas Guieysse, Marion Houot, Dimitrios Pantazis

    Background: While not originally developed for this purpose, evidence suggests that the Healthy Aging Brain Care Monitor questionnaire (HABC‐M; Monahan et al, 2012, 2014) may be a valuable instrument for assessing unawareness of cognitive decline (i.e., anosognosia) from preclinical stages of Alzheimer’s disease (AD) (Cacciamani et al, 2017). This is relevant because anosognosia may delay AD diagnosis and therapeutic interventions, with adverse consequences for patients and caregivers. However, several open questions remain: What is the actual effectiveness of this instrument across the AD spectrum? How do the cognitive, functional, and psychological subscales of the HABC‐M differ in their sensitivity to anosognosia in AD? Does the caregiver burden subscale provide additional information about AD patient’s anosognosia? The present study aimed to address these specific questions.Methods: The HABC‐M was administered to 60 participants (30 AD patients and 30 healthy controls) and their partners (caregivers/informants). A measure of self‐awareness was then estimated by computing the discrepancy scores between the participants and their partners for the different subscales of HABC‐M (with the exception of the caregiver burden subscale, which is a caregiver‐exclusive questionnaire). To evaluate whether these measures can discriminate between patients at different stages of AD and controls, we fit linear models adjusted for age, sex, and education, and computed receiver operating characteristic curves.Results: All HABC‐M discrepancy scores, as well as the caregiver burden score, were able to discriminate controls from patients in distinct AD stages. For best performance, the area‐under‐curve for the HABC‐M cognitive subscale discriminated prodromal AD versus controls with a value 0.88 [95% CI: 0.78;0.97]. Adding the caregiver burden score raised it to 0.94 [0.86;0.99].Conclusion: The HABC‐M cognitive subscale (six items) can detect anosognosia from the earliest stages of AD. Separately, the caregiver burden subscale (four items) may corroborate the suspicion of anosognosia. A short‐hybrid scale combining these 10 items, instead of the 31 items of the total HABC‐M questionnaire, could provide a practical and efficient instrument for detection of anosognosia in the clinical setting. Importantly, such an instrument could further contribute to a timely AD diagnosis.

  • Open Access

    The dual-path hypothesis for the emergence of anosognosia in Alzheimer’s disease

    by Katia Andrade, Thomas Guieysse, Takfarinas Medani, Etienne Koechlin, Dimitrios Pantazis, Bruno Dubois

    Although neurocognitive models have been proposed to explain anosognosia in Alzheimer’s disease (AD), the neural cascade responsible for its origin in the human brain remains unknown. Here, we build on a mechanistic dual-path hypothesis that brings error-monitoring and emotional processing systems as key elements for self-awareness, with distinct impacts on the emergence of anosognosia in AD. Proceeding from the notion of anosognosia as a dimensional syndrome, varying between a lack of concern about one’s own deficits (i.e., anosodiaphoria) and a complete lack of awareness of deficits, our hypothesis states that (i) unawareness of deficits would result from primary damage to the error-monitoring system, whereas (ii) anosodiaphoria would more likely result from an imbalance between emotional processing and error-monitoring. In the first case, a synaptic failure in the error-monitoring system, in which the anterior and posterior cingulate cortices play a major role, would have a negative impact on error (or deficits) awareness, preventing patients from becoming aware of their condition. In the second case, an impairment in the emotional processing system, in which the amygdala and the orbitofrontal cortex play a major role, would prevent patients from monitoring the internal milieu for relevant errors (or deficits) and assigning appropriate value to them, thus biasing their impact on the error-monitoring system. Our hypothesis stems on two scientific premises. One comes from preliminary results in AD patients showing a synaptic failure in the error-monitoring system along with a decline of awareness for cognitive difficulties at the time of diagnosis. Another comes from the somatic marker hypothesis, which proposes that emotional signals are critical to adaptive behavior. Further exploration of these premises will be of great interest to illuminate the foundations of self-awareness and improve our knowledge of the underlying paths of anosognosia in AD and other brain disorders.


  • Open Access

    Detecting Anosognosia from the Prodromal Stage of Alzheimer’s Disease

    by Thomas Guieysse, Roxane Lamothe, Marion Houot, Solofo Razafimahatratra, Takfarinas Medani, François-Xavier Lejeune, Gérard Dreyfus, André Klarsfeld, Dimitrios Pantazis, Etienne Koechlin, et al.

    Background: Though not originally developed for this purpose, the Healthy Aging Brain Care Monitor (HABC-M) seems a valuable instrument for assessing anosognosia in Alzheimer’s disease (AD). Objectives: Our study aimed at 1) investigating the validity of the HABC-M (31 items), and its cognitive, psychological, and functional subscales, in discriminating AD patients from controls; 2) exploring whether the HABC-M discrepancy scores between the self-reports of patients/controls in these different domains and the respective ratings provided by their caregivers/informants correlate with an online measure of self-awareness; 3) determining whether the caregiver burden level, also derived from the HABC-M, could add additional support for detecting anosognosia. Methods: The HABC-M was administered to 30 AD patients and 30 healthy controls, and to their caregivers/informants. A measure of online awareness was established from subjects’ estimation of their performances in a computerized experiment. Results: The HABC-M discrepancy scores distinguished AD patients from controls. The cognitive subscale discriminated the two groups from the prodromal AD stage, with an AUC of 0.88 [95% CI: 0.78;0.97]. Adding the caregiver burden level raised it to 0.94 [0.86;0.99]. Significant correlations between the HABC-M and online discrepancy scores were observed in the patients group, providing convergent validity of these methods. Conclusions: The cognitive HABC-M (six items) can detect anosognosia across the AD spectrum. The caregiver burden (four items) may corroborate the suspicion of anosognosia. The short-hybrid scale, built from these 10 items instead of the usual 31, showed the highest sensitivity for detecting anosognosia from the prodromal AD stage, which may further help with timely diagnosis.


  • Open Access

    Can a failure in the error-monitoring system explain unawareness of memory deficits in Alzheimer’s disease?

    by Solofo Razafimahatratra, Thomas Guieysse, François-Xavier Lejeune, Marion Houot, Takfarinas Medani, Gérard Dreyfus, André Klarsfeld, Nicolas Villain, Filipa Raposo Pereira, Valentina La Corte, et al.


  • Open Access

    The dual-path hypothesis for the emergence of anosognosia in Alzheimer's disease

    by Katia Andrade, Thomas Guiyesse, Takfarinas Medani, Etienne Koechlin, Dimitrios Pantazis, Bruno Dubois

    Although neurocognitive models have been proposed to explain anosognosia in Alzheimer's disease (AD), the neural cascade responsible for its origin in the human brain remains unknown. Here, we build on a mechanistic dual-path hypothesis that brings error-monitoring and emotional processing systems as key elements for self-awareness, with distinct impacts on the emergence of anosognosia in AD. Proceeding from the notion of anosognosia as a dimensional syndrome, ranging from the lack of concern about one's own deficits (i.e., anosodiaphoria) to the complete lack of awareness of deficits, our hypothesis states that (i) unawareness of deficits would result from a failure in the error-monitoring system, whereas (ii) anosodiaphoria would more likely result from an imbalance between emotional processing and error-monitoring systems. In the first case, a synaptic failure in the error-monitoring system, in which the cingulate cortex plays a major role, would have a negative impact on error (or deficits) awareness, preventing patients from becoming aware of their condition. In the second case, an impairment in the emotional processing system, in which the amygdala and orbitofrontal cortex play a major role, would prevent patients from monitoring the internal milieu for relevant errors (or deficits) and assigning appropriate value to them, thus biasing their impact on the error-monitoring system. Our hypothesis stems from two scientific premises. One comes from preliminary results in AD patients showing a synaptic failure in the error-monitoring system and decline of awareness at the time of diagnosis. Another comes from the somatic marker hypothesis, which proposes that emotional signals are critical to adaptive behavior. Further exploration will be of great interest to illuminate the foundations of self-awareness and improve our understanding of the underlying mechanisms of anosognosia in AD.

  • Open Access

    EEG-neurofeedback for promoting neuromodulation in the elderly: evidence from a double-blind study

    by Katia Andrade, Thomas Guieysse, Solofo Razafimahatratra, Nesma Houmani, André Klarsfeld, Gérard Dreyfus, Bruno Dubois, Takfarinas Medani, François Vialatte

    Background: Electroencephalography (EEG) is a non-invasive method that records the brain signals with time resolution in the millisecond range, thereby allowing the monitoring of subjects’ mental states in real time. Using appropriate biomarkers extracted from these EEG signals and presenting them back in a neurofeedback loop can foster neural compensation mechanisms by teaching subjects to modulate their brain activity. Over the last decades, several neural biomarkers of aging have been described, with growing evidence suggesting that neuromodulation may have an important role in regulating brain activity in the elderly. Methods and objectives: We used three neural biomarkers of aging, namely the Peak Alpha Frequency, the Gamma-band synchronization, and the Theta/Beta ratio, in the framework of an EEG-based brain-computer interface, with two main objectives: 1) to test whether healthy elderly people with subjective memory complaints may learn to modulate their brain activity through EEG-neurofeedback training in a double-blind, placebo-controlled study; and 2) whether that neuromodulation may have a positive impact on subjects’ cognition. Results: A significant self-modulation of two neural biomarkers that usually decline with age was observed exclusively in the group of subjects who underwent the EEG-neurofeedback training, in clear contrast with the subjects who received the sham feedback. This neuromodulation did not have a direct effect on subjects’ cognitive abilities, as measured by neuropsychological tests pre-versus post-training, probably because all the subjects accurately performed these tests already at study entry (i.e., pre-training). Conclusion: The results of this double-blind study are in line with one of the main criteria for successful neuromodulation, thus encouraging research on EEG-neurofeedback as a promising non-pharmacological intervention for promoting self-regulation of brain activity with a view to improve cognitive aging.